EUVIMEDEUVIMED entdecken
Systematische ÜbersichtNetzwerk-MetaanalyseVergleichsstudieÜbersichtsarbeitOpen Access · CC BY 4.0

Comparative Cardiovascular Outcomes of GLP ‐1 Receptor Agonists Versus Bariatric Surgery: A Systematic Review and Network Meta‐Analysis

Erfan Shirmohammadi iD, Negar Ghasemloo iD, Navid Ebrahimi iD, Narjes Mohammadzadeh iD, Amir Ehtemami iD, Mahan Babaei iD, Shakiba Fardoost

Endocrinology, Diabetes & Metabolism · 2026-09 · 9 (5)

DOI: 10.1002/edm2.70311 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Endocrinology, Diabetes & Metabolism, online erschienen am 05.09.2026. Verfasst von Erfan Shirmohammadi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Bariatric Surgery, Glucagon-Like Peptide-1 Receptor Agonists, Cardiovascular Diseases, Obesity. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Obesity, a major global health issue, heightens the risk of cardiovascular diseases, including major adverse cardiovascular events (MACE), heart failure (HF) and myocardial infarction (MI). This study provides the first network meta‐analysis (NMA) integrating direct and indirect evidence to compare the cardiovascular efficacy of bariatric surgery (BS) and glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) in individuals with obesity.

Methods

A systematic review and NMA were performed in adherence to PRISMA guidelines. PubMed, Embase, Cochrane Library and Google Scholar were searched for studies published from January 2000 to September 2024. Eligible studies reported cardiovascular outcomes, specifically MACEs, HF and MI, in patients with obesity receiving BS, GLP‐1RAs or control treatment. Fixed‐ and random‐effects models were used to analyse hazard ratios (HRs) and risk ratios (RRs), with heterogeneity assessed with I 2 and consistency through node‐splitting analysis.

Results

Forty‐three studies involving 932,380 patients were included BS was associated with significantly greater reductions in MACEs (HR 0.66; 95% CI 0.60–0.74), HF (HR 0.45; 95% CI 0.38–0.53) and MI (HR 0.53; 95% CI 0.45–0.63) compared with controls in random‐effects models. GLP‐1RAs reduced MACEs (HR 0.85; 95% CI 0.77–0.94) but showed non‐significant effects on HF and MI. Despite high heterogeneity ( I 2 : 66%–93%), directional consistency was observed across studies.

Conclusions

BS demonstrated more consistent and statistically significant reductions in all cardiovascular outcomes compared to GLP‐1RAs, which showed more variable efficacy, particularly for HF and MI. Nevertheless, GLP‐1RAs remain effective evidence‐based alternatives for cardiovascular risk reduction in patients who are not candidates for surgery, but future studies on newer GLP‐1RAs are required. The high heterogeneity across studies highlights the need for cautious interpretation. These results may inform individualized treatment selection in patients with obesity at high cardiovascular risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bariatric SurgeryGlucagon-Like Peptide-1 Receptor AgonistsCardiovascular DiseasesObesityHumansTreatment Outcome

Stichwörter der Autor:innen

GLP‐1 receptor agonistsbariatric surgerycardiovascular diseasescardiovascular risk reductionheart failuremajor adverse cardiovascular events (MACE)myocardial infarctionnetwork meta‐analysisobesitysystematic review

Substanzen

Glucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Department of Surgery, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Iran Azad University of Medical Sciences, Tehran Medical Branch, Tehran, Iran.

ORCID-Profile: Erfan Shirmohammadi, Negar Ghasemloo, Navid Ebrahimi, Narjes Mohammadzadeh, Amir Ehtemami, Mahan Babaei

Zitieren

APA

Shirmohammadi, E., Ghasemloo, N., Ebrahimi, N., Mohammadzadeh, N., Ehtemami, A., Babaei, M., & Fardoost, S. (2026). Comparative Cardiovascular Outcomes of GLP ‐1 Receptor Agonists Versus Bariatric Surgery: A Systematic Review and Network Meta‐Analysis. Endocrinology, Diabetes & Metabolism, 9(5). https://doi.org/10.1002/edm2.70311

Vancouver

Shirmohammadi E, Ghasemloo N, Ebrahimi N, Mohammadzadeh N, Ehtemami A, Babaei M, et al. Comparative Cardiovascular Outcomes of GLP ‐1 Receptor Agonists Versus Bariatric Surgery: A Systematic Review and Network Meta‐Analysis. Endocrinology, Diabetes & Metabolism. 2026;9(5). doi:10.1002/edm2.70311

BibTeX
@article{Shirmohammadi2026,
  author = {Shirmohammadi, Erfan and Ghasemloo, Negar and Ebrahimi, Navid and Mohammadzadeh, Narjes and Ehtemami, Amir and Babaei, Mahan and Fardoost, Shakiba},
  title = {Comparative Cardiovascular Outcomes of GLP ‐1 Receptor Agonists Versus Bariatric Surgery: A Systematic Review and Network Meta‐Analysis},
  journal = {Endocrinology, Diabetes & Metabolism},
  year = {2026},
  volume = {9},
  number = {5},
  doi = {10.1002/edm2.70311}
}
Kostenlos starten →